EUVIMEDEUVIMED entdecken
Kohortenstudie

The effectiveness and safety of intrauterine infusion of autologous regulatory T cells (Tregs) in patients with recurrent pregnancy loss and low levels of endometrial FoxP3 + cells: A retrospective cohort study

Songchen Cai, Su Dai, Rong Lin, Chunyu Huang, Yong Zeng iD, Lianghui Diao iD, Ruochun Lian iD, Wenwei Tu

American Journal of Reproductive Immunology · 2023

DOI: 10.1111/aji.13735 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift American Journal of Reproductive Immunology, 2023. Verfasst von Songchen Cai und 7 weiteren Autor:innen. Beteiligte Einrichtung: Shenzhen Key Laboratory of Reproductive Immunology for Peri-implantation, Shenzhen Zhongshan Institute for Reproduction and Genetics, Fertility Cente…. Hauptthemen laut MEDLINE: T-Lymphocytes, Regulatory, Abortion, Habitual. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 48 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Problem Regulatory T cells (Tregs) are a specialized type of T cells that help maintain immune tolerance and homeostasis. The potential of Tregs cell‐based therapies in treating diseases has been demonstrated in several clinical trials, which have shown promising outcomes and high safety in autoimmune diseases, transplant rejection, and graft‐versus‐host disease. However, their effectiveness and safety in improving endometrial receptivity and reducing pregnancy loss in human reproduction are unknown. Method of study The study used a retrospective design and included patients with recurrent pregnancy loss (RPL) and lower levels of endometrial FoxP3 + Tregs. Patients in the Tregs group ( n = 33) received intrauterine Tregs infusion three times during the follicular phase, while the control group ( n = 28) did not receive any intrauterine infusion.

Results

The intrauterine infusion of autologous Tregs increased the levels of FoxP3 + Tregs and CD56 + NK cells. Patients in the Treg group had higher live birth rates and lower miscarriage rates, especially early miscarriage rates. However, the two groups had no differences in the implantation rate, clinical pregnancy rate, and percentage of preterm delivery.

Conclusions

The findings suggest that intrauterine Tregs infusion may be a potential therapeutic approach for RPL. Further research in larger clinical trials is needed to confirm these findings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

T-Lymphocytes, RegulatoryAbortion, HabitualPregnancyFemaleInfant, NewbornHumansRetrospective StudiesEndometriumEmbryo Implantation

Stichwörter der Autor:innen

Endometrial receptivityIntrauterine infusionMaternal-fetal immunomodulatoryRecurrent pregnancy lossRegulatory T cells

Autor:innen und Institutionen

  • Shenzhen Key Laboratory of Reproductive Immunology for Peri-implantation, Shenzhen Zhongshan Institute for Reproduction and Genetics, Fertility Center, Shenzhen Zhongshan Urology Hospital, Shenzhen, China.
  • Department of Paediatrics and Adolescent Medicine, School of Clinical Medicine, The University of Hong Kong, Hong Kong, China.

ORCID-Profile: Yong Zeng, Lianghui Diao, Ruochun Lian

Zitieren

APA

Cai, S., Dai, S., Lin, R., Huang, C., Zeng, Y., Diao, L., Lian, R., & Tu, W. (2023). The effectiveness and safety of intrauterine infusion of autologous regulatory T cells (Tregs) in patients with recurrent pregnancy loss and low levels of endometrial FoxP3 + cells: A retrospective cohort study. American Journal of Reproductive Immunology. https://doi.org/10.1111/aji.13735

Vancouver

Cai S, Dai S, Lin R, Huang C, Zeng Y, Diao L, et al. The effectiveness and safety of intrauterine infusion of autologous regulatory T cells (Tregs) in patients with recurrent pregnancy loss and low levels of endometrial FoxP3 + cells: A retrospective cohort study. American Journal of Reproductive Immunology. 2023. doi:10.1111/aji.13735

BibTeX
@article{Cai2023,
  author = {Cai, Songchen and Dai, Su and Lin, Rong and Huang, Chunyu and Zeng, Yong and Diao, Lianghui and Lian, Ruochun and Tu, Wenwei},
  title = {The effectiveness and safety of intrauterine infusion of autologous regulatory T cells (Tregs) in patients with recurrent pregnancy loss and low levels of endometrial FoxP3 + cells: A retrospective cohort study},
  journal = {American Journal of Reproductive Immunology},
  year = {2023},
  doi = {10.1111/aji.13735}
}
Kostenlos starten →